We are live on ! Find out more
KTOVW

Kitov Pharma Ltd. Warrants
KTOVW

Delisted

KTOVW was delisted on the 23rd of November, 2020.

Back to rankings

4 hedge funds and large institutions have $350K invested in Kitov Pharma Ltd. Warrants in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more capital invested

Capital invested by funds: $163K → $350K (+$187K)

33% more funds holding

Funds holding: 3 → 4 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$3.11K

Top Sellers

Rank Fund Capital Flow
1
ICM
Ionic Capital Management
New York
-$6.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
ICM
1
Ionic Capital Management
New York
$200K -$6.3K -10,000 -5%
SM
2
Sabby Management
Florida
$126K – – –
BA
3
BlackRock Advisors
Delaware
$19K – – –
UBS Group
4
UBS Group
Switzerland
$5K +$3.11K +4,940 New

KTOVW Hedge Fund Activity: Q1 2016 in Review

4 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q1 2016, worth a combined $350K — up 115% from $163K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new KTOVW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $3.11K. The largest seller was Ionic Capital Management, cutting an estimated $6.3K.

  • 4 institutional investors held Kitov Pharma Ltd. Warrants (KTOVW) as of Q1 2016, up from 3 in Q4 2015.
  • Funds reported $350K of Kitov Pharma Ltd. Warrants stock for Q1 2016, up 115% quarter-over-quarter.
  • 1 fund opened new Kitov Pharma Ltd. Warrants positions in Q1 2016 and 0 closed out, a net change of +1 holder.
  • The largest Kitov Pharma Ltd. Warrants buyer in Q1 2016 was UBS Group, an estimated $3.11K added.
  • The largest Kitov Pharma Ltd. Warrants seller in Q1 2016 was Ionic Capital Management, an estimated $6.3K sold.

Based on aggregated 13F filings for Q1 2016.